if the new Menactra (meningococcal conjugate vaccine) causes Guillain-Barre Syndrome

November 2005

Patients and parents are asking if the new Menactra (meningococcal conjugate vaccine) causes Guillain-Barre Syndrome.

This is based on a handful of cases of Guillain-Barre...in older adolescents 2 to 5 weeks after receiving Menactra.

The rapid bilateral ascending muscle weakness and temporary paralysis is a big worry for parents.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote